Tirzepatide has emerged as a novel treatment option for individuals with type 2 diabetes. This dual-acting medication, administered via subcutaneous injection, effectively targets both insulin levels and appetite https://aoifexcvk069817.actoblog.com/34327325/tirzepatide-a-new-frontier-in-type-2-diabetes-treatment